These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14969653)

  • 1. Interpretations of 'appropriate' minority inclusion in clinical research.
    Corbie-Smith G; Miller WC; Ransohoff DF
    Am J Med; 2004 Feb; 116(4):249-52. PubMed ID: 14969653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hispanic research: implications of the National Institutes of Health guidelines on inclusion of women and minorities in clinical research.
    Caban CE
    J Natl Cancer Inst Monogr; 1995; (18):165-9. PubMed ID: 8562217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV/AIDS: a minority health issue.
    Cargill VA; Stone VE
    Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities among clinical research investigators.
    Getz K; Faden L
    Am J Ther; 2008; 15(1):3-11. PubMed ID: 18223347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigators' assessment of NIH mandated inclusion of women and minorities in research.
    Corbie-Smith GM; Durant RW; St George DM
    Contemp Clin Trials; 2006 Dec; 27(6):571-9. PubMed ID: 16843069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting and representation of race/ethnicity in published randomized trials.
    Berger JS; Melloni C; Wang TY; Dolor RJ; Frazier CG; Samad Z; Peterson ED; Mark DB; Newby LK
    Am Heart J; 2009 Nov; 158(5):742-7. PubMed ID: 19853691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
    Newman LA; Lee CT; Parekh LP; Stewart AK; Thomas CR; Beltran RA; Lucci A; Green B; Ota D; Nelson H;
    Cancer; 2006 Jan; 106(1):188-95. PubMed ID: 16333856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
    J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to improving recruitment and retention of minority elders participating in research: examples from selected research groups including the National Institute on Aging's Resource Centers for Minority Aging Research.
    Stahl SM; Vasquez L
    J Aging Health; 2004 Nov; 16(5 Suppl):9S-17S. PubMed ID: 15448284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy.
    Bruner DW; Jones M; Buchanan D; Russo J
    J Clin Oncol; 2006 May; 24(14):2209-15. PubMed ID: 16682741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing the divide: diverse populations and cancer survivorship.
    Guidry JJ; Torrence W; Herbelin S
    Cancer; 2005 Dec; 104(11 Suppl):2577-83. PubMed ID: 16258930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigator beliefs and reported success in recruiting minority participants.
    Williams IC; Corbie-Smith G
    Contemp Clin Trials; 2006 Dec; 27(6):580-6. PubMed ID: 16839822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying justice in clinical trials for diverse populations.
    Tilburt J; Ford JG; Howerton MW; Gary TL; Lai GY; Bolen S; Baffi C; Wilson RF; Tanpitukpongse TP; Powe NR; Bass EB; Sugarman J
    Clin Trials; 2007; 4(3):264-9. PubMed ID: 17715253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studying vulnerable populations: lessons from the Roma minority.
    Kósa K; Adány R
    Epidemiology; 2007 May; 18(3):290-9. PubMed ID: 17435436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conducting research with urban elders: issues of recruitment, data collection, and home visits.
    Wrobel AJ; Shapiro NE
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 1():S34-8. PubMed ID: 10369516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation in cancer trials: recruitment of underserved populations.
    Paskett ED; Katz ML; DeGraffinreid CR; Tatum CM
    Clin Adv Hematol Oncol; 2003 Oct; 1(10):607-13. PubMed ID: 16258457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.
    Newman LA; Hurd T; Leitch M; Kuerer HM; Diehl K; Lucci A; Giuliano A; Hunt KK; Putnam W; Wells SA
    J Am Coll Surg; 2004 Oct; 199(4):644-51. PubMed ID: 15454152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The participation of underrepresented minorities in clinical research.
    Noah BA
    Am J Law Med; 2003; 29(2-3):221-45. PubMed ID: 12961806
    [No Abstract]   [Full Text] [Related]  

  • 19. Why ethnic minority groups are under-represented in clinical trials: a review of the literature.
    Hussain-Gambles M; Atkin K; Leese B
    Health Soc Care Community; 2004 Sep; 12(5):382-8. PubMed ID: 15373816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inclusion of minority groups in clinical trials: problems of under representation and under reporting of data.
    Rochon PA; Mashari A; Cohen A; Misra A; Laxer D; Streiner DL; Clark JP; Dergal JM; Gold J
    Account Res; 2004; 11(3-4):215-23. PubMed ID: 15812967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.